Clinical trials for Altitude sickness

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Altitude sickness. For all clinical trials, go to clinical trials search

This list shows clinical trials for Altitude sickness

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Altitude sickness
Title Recruitment status Location
Estudio aleatorizado, doble ciego, controlado con placebo, de grupos paralelos, para determinar si la adición de Aliskiren al tratamiento convencional, en pacientes con diabetes tipo 2 y alto riesgo de eventos cardiovasculares y renales, reduce la morbilidad y mortalidad de origen cardiovascular y renal respecto al tratamiento convencional - ALTITUDE Not Recruiting United Kingdom
Intracranial Pressure in Experimental Models of Headache Not recruiting United Kingdom
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) Not recruiting United Kingdom
A randomized, double-blind, placebo-controlled, parallel-group study to determine whether, in patients with type 2 diabetes at high risk for cardiovascular and renal events, aliskiren, on top of conventional treatment, reduces cardiovascular and renal morbidity and mortality - ALTITUDE: ALiskiren Trial In Type 2 diabetes Using cardiorenal Disease Endpoints Not Recruiting United Kingdom
A clinical trial to determine whether, in patients with type 2 diabetes at high risk for cardiovascular and renal events, aliskiren, on top of conventional treatment, reduces cardiovascular and renal morbidity and mortality Not Recruiting United Kingdom
Performance of Continuous Glucose Monitoring Systems at Altitude Not recruiting United Kingdom
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints Not Recruiting United Kingdom
Anti-Oxidant Supplementation for the Prevention of Acute Mountain Sickness Not recruiting United Kingdom
A clinical trial to determine whether, in patients with type 2 diabetes at high risk for cardiovascular and renal events, aliskiren, on top of conventional treatment, reduces cardiovascular and renal morbidity and mortality Not Recruiting United Kingdom
A randomized, double-blind, placebo-controlled, parallel-group study to determine whether, in patients with type 2 diabetes at high risk for cardiovascular and renal events, aliskiren, on top of conventional treatment, reduces cardiovascular and renal morbidity and mortality - ALTITUDE Not Recruiting United Kingdom

Page last reviewed: 15/07/2011

Next review due: 15/07/2013